Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TIROFIBAN for Cardiovascular event prophylaxis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where TIROFIBAN was used for Cardiovascular event prophylaxis.

Most Reported Side Effects for TIROFIBAN

Side Effect Reports % Deaths Hosp.
Haemorrhage 341 15.7% 1 2
Angina pectoris 177 8.2% 0 19
Haemorrhage intracranial 170 7.9% 2 1
Myocardial infarction 159 7.3% 5 1
Thrombocytopenia 150 6.9% 10 23
Cardiac failure acute 116 5.4% 0 0
Death 110 5.1% 110 5
Acute respiratory failure 99 4.6% 1 3
Cerebral haemorrhage 84 3.9% 15 7
Cardiac failure 68 3.1% 5 1
Vascular stent thrombosis 63 2.9% 2 10
Infarction 53 2.5% 0 0
Cardiac death 29 1.3% 28 0
Arrhythmia 25 1.2% 0 0
Gastrointestinal haemorrhage 24 1.1% 3 3

Other Indications for TIROFIBAN

Antiplatelet therapy (1,513) Ischaemic stroke (220) Off label use (162) Acute myocardial infarction (75) Product used for unknown indication (58) Acute coronary syndrome (32) Angina unstable (23) Myocardial infarction (13) Thrombosis (11) Cerebral infarction (10)

Other Drugs Used for Cardiovascular event prophylaxis

ATORVASTATIN (4,792) LIPITOR (1,863) ASPIRIN (950) ASPIRIN DL-LYSINE (653) CANAKINUMAB (560) RIVAROXABAN (432) CLOPIDOGREL BISULFATE (414) TICAGRELOR (351) SEMAGLUTIDE (207) ICOSAPENT ETHYL (196)

Related Pages

TIROFIBAN Full Profile All Cardiovascular event prophylaxis Drugs TIROFIBAN Demographics TIROFIBAN Timeline